KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Return on Sales (2016 - 2025)

Globus Medical's Return on Sales history spans 15 years, with the latest figure at 0.17% for Q4 2025.

  • For Q4 2025, Return on Sales rose 13.0% year-over-year to 0.17%; the TTM value through Dec 2025 reached 0.18%, up 14.0%, while the annual FY2025 figure was 0.18%, 14.0% up from the prior year.
  • Return on Sales reached 0.17% in Q4 2025 per GMED's latest filing, up from 0.15% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.27% in Q2 2025 to a low of 0.01% in Q1 2024.
  • Average Return on Sales over 5 years is 0.13%, with a median of 0.17% recorded in 2022.
  • The largest YoY upside for Return on Sales was 31bps in 2021 against a maximum downside of -27bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 0.08% in 2021, then soared by 153bps to 0.2% in 2022, then crashed by -88bps to 0.02% in 2023, then surged by 65bps to 0.04% in 2024, then skyrocketed by 322bps to 0.17% in 2025.
  • Per Business Quant, the three most recent readings for GMED's Return on Sales are 0.17% (Q4 2025), 0.15% (Q3 2025), and 0.27% (Q2 2025).